MAP2K7 and neoplasm: We found the dual and triple combination to be able to not only decrease tumor growth in vivo but also reduce the active (i.e., phosphorylated) forms of MEK and ERK (i.e., p-MEK and p-ERK) in LGSOC cells by Western blot assays.